These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19546396)

  • 21. Leukotrienes and atherosclerosis.
    Khan Z; Tripathi CD
    Indian Heart J; 2005; 57(2):175-80. PubMed ID: 16013362
    [No Abstract]   [Full Text] [Related]  

  • 22. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapies for type 2 diabetes and coronary artery disease.
    Bertoldi EG; Weinert LS; Polanczyk CA
    N Engl J Med; 2009 Oct; 361(14):1408; author reply 1409-10. PubMed ID: 19802917
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of radio and chemotherapy of malignant neoplasms on the development of atherosclerosis, coronary heart disease, and lipid spectrum].
    Syrkin AL; Kuprina IV; Avdeev IuV; Poltavskaia MG; Struchkova TIa; Pivnik AV
    Klin Med (Mosk); 2008; 86(11):28-31. PubMed ID: 19177789
    [No Abstract]   [Full Text] [Related]  

  • 25. The silent killer.
    Omar MI; Shakeel A
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):749-50. PubMed ID: 16398961
    [No Abstract]   [Full Text] [Related]  

  • 26. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
    Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
    Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How much is too much? Interleukin-6 and its signalling in atherosclerosis.
    Schuett H; Luchtefeld M; Grothusen C; Grote K; Schieffer B
    Thromb Haemost; 2009 Aug; 102(2):215-22. PubMed ID: 19652871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distinct role of secondary prevention in patients with prior coronary interventions.
    Colmenarez H; Escaned J
    EuroIntervention; 2009 May; 5 Suppl D():D131-8. PubMed ID: 19736062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program.
    Brilakis ES; Hernandez AF; Dai D; Peterson ED; Banerjee S; Fonarow GC; Cannon CP; Bhatt DL
    Circulation; 2009 Aug; 120(7):560-7. PubMed ID: 19652090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery disease in young adults.
    Klein LW; Nathan S
    J Am Coll Cardiol; 2003 Feb; 41(4):529-31. PubMed ID: 12598060
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced cardiovascular mortality in hemophilia despite normal atherosclerotic load.
    Makris M; Van Veen JJ
    J Thromb Haemost; 2012 Jan; 10(1):20-2. PubMed ID: 22018281
    [No Abstract]   [Full Text] [Related]  

  • 32. The ten most commonly asked questions about infection as a cause of atherosclerotic heart disease.
    Muhlestein JB
    Cardiol Rev; 1999; 7(5):251-3. PubMed ID: 11208234
    [No Abstract]   [Full Text] [Related]  

  • 33. Phospholipase A2 inhibitors.
    Garcia-Garcia HM; Serruys PW
    Curr Opin Lipidol; 2009 Aug; 20(4):327-32. PubMed ID: 19550325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
    Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
    Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis: cell biology and lipoproteins.
    Daugherty A; Lu H; Rateri DL
    Curr Opin Lipidol; 2009 Jun; 20(3):260-1. PubMed ID: 19433924
    [No Abstract]   [Full Text] [Related]  

  • 36. Macrophage diversity and polarization in atherosclerosis: a question of balance.
    Mantovani A; Garlanda C; Locati M
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1419-23. PubMed ID: 19696407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bibliography current world literature.
    Coron Artery Dis; 2009 Sep; 20(6):428-9. PubMed ID: 19696599
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical determinants of ckit-positive cardiac cell yield in coronary disease.
    Aghila Rani KG; Jayakumar K; Sarma PS; Kartha CC
    Asian Cardiovasc Thorac Ann; 2009 Apr; 17(2):139-42. PubMed ID: 19592542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis.
    Lee JR; Kim JK; Lee SJ; Kim KP
    Arch Pharm Res; 2009 Aug; 32(8):1109-18. PubMed ID: 19727603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.